Immunohistochemical staining of thyroidectomy specimens for pten can aid in the identification of patients with cowden syndrome

American Journal of Surgical Pathology

Volumn 35, Issue 10, 2011, Pages 1505-1511

  Barletta, Justine A ^a   Bellizzi, Andrew M ^a   Hornick, Jason L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

adenomatous nodules; Cowden syndrome; PTEN

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PTEN PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CONGENITAL TUMOR; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; THYROID DISEASE; THYROID GLAND; THYROID TUMOR; THYROIDECTOMY;

ADULT; AGED; FEMALE; HAMARTOMA SYNDROME, MULTIPLE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PTEN PHOSPHOHYDROLASE; THYROID DISEASES; THYROID GLAND; THYROID NEOPLASMS; THYROIDECTOMY; YOUNG ADULT;

EID: 80053375204     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31822fbc7d     Document Type: Article

References (22)

1. Bennett KL, Mester J, Eng C. Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome. JAMA. 2010;304: 2724-2731
2. Daly MB, Axilbund JE, Buys S, et al. Genetic/familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw. 2010; 8:562-594
3. Eng C. Will the real Cowden syndrome please stand up: revised diagnostic criteria. J Med Genet. 2000;37:828-830
4. Gimm O, Attie-Bitach T, Lees JA, et al. Expression of the PTEN tumour suppressor protein during human development. Hum Mol Genet. 2000;9:1633-1639 (Pubitemid 30427000)
5. Gustafson S, Zbuk KM, Scacheri C, et al. Cowden syndrome. Semin Oncol. 2007;34:428-434 (Pubitemid 47503276)
6. Harach HR, Soubeyran I, Brown A, et al. Thyroid pathologic findings in patients with Cowden disease. Ann Diagn Pathol. 1999; 3:331-340
7. Huang SC, Lee JK, Smith EJ, et al. Evidence for an hMSH3 defect in familial hamartomatous polyps. Cancer. 2011;117:492-500
8. Laury AR, Bongiovanni M, Tille JC, et al. Thyroid pathology in PTEN-hamartoma tumor syndrome: characteristic findings of a distinct entity. Thyroid. 2010;21:135-144
9. Liaw D, Marsh DJ, Li J, et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet. 1997;16:64-67 (Pubitemid 27198157)
10. Longy M, Lacombe D. Cowden disease: report of a family and review. Ann Genet. 1996;39:35-42 (Pubitemid 26143482)
11. Marsh DJ, Kum JB, Lunetta KL, et al. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet. 1999;8:1461-1472 (Pubitemid 29374079)
12. NelenMR, Padberg GW, Peeters EA, et al. Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet. 1996;13:114-116 (Pubitemid 126528240)
13. Nelen MR, Kremer H, Konings IB, et al. Novel PTEN mutations in patients with Cowden disease: absence of clear genotype-phenotype correlations. Eur J Hum Genet. 1999;7:267-273 (Pubitemid 29213732)
14. Ni Y, Zbuk KM, Sadler T, et al. Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes. Am J Hum Genet. 2008;83:261-268
15. Pilarski R, Eng C. Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome. J Med Genet. 2004;41:323-326 (Pubitemid 38608513)
16. Sangale Z, Prass C, Carlson A, et al. A robust immunohistochemical assay for detecting PTEN expression in human tumors. Appl Immunohistochem Mol Morphol. 2011;19:173-183
17. Smith JR, Marqusee E, Webb S, et al. Thyroid nodules and cancer in children with PTEN hamartoma tumor syndrome. J Clin Endocrinol Metab. 2011;96:34-37
18. Tan MH, Mester J, Peterson C, et al. A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands. Am J Hum Genet. 2011;88:42-56
19. Teresi RE, Zbuk KM, Pezzolesi MG, et al. Cowden syndromeaffected patients with PTEN promoter mutations demonstrate abnormal protein translation. Am J Hum Genet. 2007;81:756-767 (Pubitemid 47596543)
20. Zambrano E, Holm I, Glickman J, et al. Abnormal distribution and hyperplasia of thyroid C-cells in PTEN-associated tumor syndromes. Endocr Pathol. 2004;15:55-64 (Pubitemid 38951809)
21. Zhou XP, Marsh DJ, Morrison CD, et al. Germline inactivation of PTEN and dysregulation of the phosphoinositol-3-kinase/Akt pathway cause human Lhermitte-Duclos disease in adults. Am J Hum Genet. 2003;73:1191-1198 (Pubitemid 37414231)
22. Zhou XP, Waite KA, Pilarski R, et al. Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway. Am J Hum Genet. 2003; 73:404-411